OR WAIT null SECS
Victoria Johnson joined the MJH Life Sciences in 2020 and has written for NeurologyLive, CGTLive, and now HCPLive. You can reach her at vjohnson@mjhlifesciences.com
October 29, 2024
Article
Four of 5 participants with follow-up reaching 3 months have achieved SRI-4 disease responses.
October 28, 2024
Video
Abdellatif discussed the importance of screening for osteopenia in patients with severe kidney disease.
October 27, 2024
Refardt discussed findings from the largest hyponatremia trial ever conducted, including 2174 participants across 9 European centers.
October 26, 2024
The dapagliflozin group had an average eGFR rate of -2.24 mL/min/1.73 m2 compared to -3.67 mL/min/1.73 m2 in the control group after about 1.5 years of follow-up.